Literature DB >> 23287290

Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies.

Vlatka Zoldoš1, Tomislav Horvat, Gordan Lauc.   

Abstract

Majority of eukaryotic proteins are glycosylated and their glycan moieties have numerous important structural, functional and regulatory roles. Because of structural complexity of glycans and technological limitations glycomics, and particularly glycoproteomics was not able to follow rapid progress in genomics and proteomics over last 30 years. However, the field of glycan has been progressing rapidly and first large-scale studies of the glycome have been completed recently. These studies have revealed significant differences in glycome composition between individuals, which may contribute to the human phenotypic variability. The current state-of-the-art in high-throughput glycomics and its integration with genomics, epigenomics and lipidomics is reviewed in this article.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23287290     DOI: 10.1016/j.cbpa.2012.12.007

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  21 in total

1.  Spatial and temporal diversity of glycome expression in mammalian brain.

Authors:  Jua Lee; Seungshin Ha; Minsoo Kim; Seong-Wook Kim; Jaekyung Yun; Sureyya Ozcan; Heeyoun Hwang; In Jung Ji; Dongtan Yin; Maree J Webster; Cynthia Shannon Weickert; Jae-Han Kim; Jong Shin Yoo; Rudolf Grimm; Sabine Bahn; Hee-Sup Shin; Hyun Joo An
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

Review 2.  Humanizing glycosylation pathways in eukaryotic expression systems.

Authors:  Amjad Hayat Khan; Hadi Bayat; Masoumeh Rajabibazl; Suriana Sabri; Azam Rahimpour
Journal:  World J Microbiol Biotechnol       Date:  2016-11-11       Impact factor: 3.312

Review 3.  The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets.

Authors:  Jianli Ma; Yuwei Deng; Minghui Zhang; Jinming Yu
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 4.  Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders.

Authors:  Ryan P Berger; Michelle Dookwah; Richard Steet; Stephen Dalton
Journal:  Bioessays       Date:  2016-09-26       Impact factor: 4.345

5.  Glycomics: Immunoglobulin G N-Glycosylation Associated with Mammary Gland Hyperplasia in Women.

Authors:  Zixiu Meng; Cancan Li; Guoyong Ding; Weijie Cao; Xizhu Xu; Yuanyuan Heng; Yang Deng; Yuejin Li; Xiaoyu Zhang; Dong Li; Wei Wang; Youxin Wang; Weijia Xing; Haifeng Hou
Journal:  OMICS       Date:  2020-08-24

Review 6.  Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.

Authors:  Gordon Greville; Amanda McCann; Pauline M Rudd; Radka Saldova
Journal:  Epigenetics       Date:  2016-09-30       Impact factor: 4.528

7.  Advancing a High Throughput Glycotope-centric Glycomics Workflow Based on nanoLC-MS2-product Dependent-MS3 Analysis of Permethylated Glycans.

Authors:  Cheng-Te Hsiao; Po-Wei Wang; Hua-Chien Chang; Yen-Ying Chen; Shui-Hua Wang; Yijuang Chern; Kay-Hooi Khoo
Journal:  Mol Cell Proteomics       Date:  2017-10-24       Impact factor: 5.911

8.  A simple lectin-based biochip might display the potential clinical value of glycomics in patients with spontaneous intracerebral hemorrhage.

Authors:  Lei Ye; Yong-Sheng Fang; Xiao-Xue Li; Yi Gao; Sheng-Sheng Liu; Qiang Chen; Qiang Wu; Hong-Wei Cheng; Wei-Dong Du
Journal:  Ann Transl Med       Date:  2021-04

Review 9.  A Bittersweet Computational Journey among Glycosaminoglycans.

Authors:  Giulia Paiardi; Maria Milanesi; Rebecca C Wade; Pasqualina D'Ursi; Marco Rusnati
Journal:  Biomolecules       Date:  2021-05-15

Review 10.  Translational glycobiology: from bench to bedside.

Authors:  John Axford; Azita Alavi; Rick Cummings; Gordan Lauc; Ghislain Opdenakker; Celso Reis; Pauline Rudd
Journal:  J R Soc Med       Date:  2019-09-17       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.